Nasdaq

BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease

FRANKLIN LAKES, N.J., May 28, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to initiate a patient data ...
Seeking Alpha

BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease

FRANKLIN LAKES, N.J., Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, today announced the enrollment of the first patient in the ...
AOL

BD's (BDX) Rotarex Atherectomy System Gets FDA 510 (k) Clearance

Becton, Dickinson and Company BDX, also popularly known as BD, recently received 510(k) clearance for expanded indications from the FDA for the Rotarex Atherectomy System. It is important to mention ...
Becker's Hospital Review

FDA warns of injury risk with catheter system

The FDA issued a warning regarding the Rotarex Atherectomy System, a device used to break up and remove the thrombus from peripheral arteries. Bard Peripheral Vascular, a subsidiary of Becton, ...
Nasdaq

BD's (BDX) Rotarex Atherectomy System Gets FDA 510 (k) Clearance

Becton, Dickinson and Company BDX, also popularly known as BD, recently received 510(k) clearance for expanded indications from the FDA for the Rotarex Atherectomy System. It is important to mention ...